🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Many congrats on this great achievement! So proud of you!

سال ۹۰ مشاور IT مدیرعامل یک بانک بودم. فهمیدم شرکتی هزاران روتر Cisco را با افزودن یک برد کوچک در جعبه‌ای با برند خودش ۳ برابر قیمت به آن بانک و چند بانک دولتی فروخته. ده‌ها میلیون دلار تفاوت قیمت بود. موضوع را به هیات مدیره اطلاع دادم. مدتی بعد، حراست بانک مرا اخراج کرد. پایان.

Huge congratulations to Dr. Dr. Hooman Djaladat for receiving this prestigious and very well-deserved award! We are lucky to have you as our mentor at USC Urology! @KeckMedUSC Keck School of Medicine of USC

"Bullying is a means for mediocre scientists to rise to the top. Some star academics reached their position because they are bullies, not in spite of it." - Excellent piece about bullying in academia (and really any other professional environment). nature.com/articles/s4156…

Such a recognition and honor. Thank you to the whole team, #AUA2023 and of course patients for their trust! Joshua Meeks Stephen Boorjian, MD Wes Kassouf Christian D. Fankhauser jim catto Bernie Bochner, MD Roswell Park Genitourinary Oncology @gorejohn Stephen B. Williams, MD, MBA, MS, FACHE Saum Ghodoussipour

Very sad to hear. He wrote one of my letters for promotion to associate professor when I was at OHSU- always generous with his time and wisdom. A true giant in the field and the legacy of his contributions will live on forever.

nature.com/articles/s4159… Sumanta K. Pal, MD, FASCO Sia Daneshmand, M.D. Ronac Mamtani Horowitz Lab @Icahn School of Medicine Mount Sinai Reza Mehrazin, MD Bhardwaj Lab Dr. John Sfakianos Neeraj Agarwal, MD, FASCO Hoosier Cancer Icahn School of Medicine at Mount Sinai Lipschultz Precision Immunology Institute

Our recently published review on risk stratification in #UTUC: I'd like to extend my gratitude to Masoud Bitaraf and mahmood ghafoori for their hard work and outstanding contributions. Special thanks to Dr. Hooman Djaladat and Alireza Ghoreifi, MD for the invitation mdpi.com/2072-6694/15/2…

Dr. William Kelly presented the results of a phase 1 trial with AMG-509 (xaluritamig), a new STEAP-CD3 engager immunotherapy for heavely pre-treated metastatic prostate cancer patients. Amazing responses seen, and cytokine releasing syndrome was the major AE. The immunotherapy

Applause mid-presentation marking the moment the standard of care changed in #bladdercancer The data speaks for itself, but Tom Powles spoke for all of us thanking patients, not just those on EV 302, but the many who came before allowing us to celebrate this milestone #EVPembro

Check this video as well! The incredible Sia Daneshmand, M.D.! This was at Tahoe during the WSAUA23...

Excellent talk by Anne Schuckman USC Urology on the necessity of RCx despite CR following NAC. Society of Urologic Oncology #SUO23 #BladderCancer

FINALLY - what I have been looking forward to prove for 20 years: the detection performance of DRE for PCa is so weak that we can forego this exam. Hope the guidelines take this evidence to stop recommending DRE for PCa screening/early detection. sciencedirect.com/science/articl…

Great debate on renaming Gleason 3+3 #prostatecancer between Scott Eggener (for) and Martin Gleave (against)! The debate is still ongoing! #GU24

Theodore et al. provide an overview of intestinal anatomy and the pathophysiology and etiology of intestinal ischemia. Read the full review: eviden.cc/48uEJok #Surgery #CriticalCare

Good day for #bladdercancer BOND-3 results presented by Mark Tyson showing 75.2% CR at anytime for pts with BCG unresponsive disease. Over half of non responders converted to CR with repeat dosing. 96.7% PFS@12 mos. More trials to come through Society of Urologic Oncology Roger Li CG Oncology, Inc.

Huge congratulations for your publication in Nature Reviews Urology! Your dedication, intellect, and unwavering integrity in research are truly commendable. Keep shining bright!

Excited to share my third publication in Clinical Genitourinary Cancer.🚀 Huge thanks to Erfan Amini for the supervision and Masoud Bitaraf Mohammadreza Ghahari, MD for the incredible collaboration. #BladderCancer #Oncology sciencedirect.com/science/articl…

Is #Viagra good for my #brain, too?! Read our meta-analysis on PDE5-inhibitors and #Alzheimers nature.com/articles/s4440… npj Journals Nature Portfolio Springer Nature Erfan Amini Parham Torabinavid Image: edrugstore.com

Our recent publication in European Urology Oncology demonstrates - for the first time -that an AI-powered histologic biomarker (CHAI) can predict response to intravesical BCG vs. gemcitabine/docetaxel in high-grade NMIBC. A critical step forward in precision intravesical therapy.